• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


New posts

Post thread…
What's new New posts New profile posts Latest activity
Oncology division
Replies
531
Views
82K
Eisai
anonymous
Abbvie Migraine
Replies
12
Views
3K
AbbVie
anonymous
Syndax
Replies
39
Views
7K
Biotech Startups
anonymous
Why are so many leaving the Dynasty?
Replies
24
Views
2K
Amgen
anonymous
Did Carol in Fleet get axed too?
Replies
2
Views
226
Amgen
anonymous
Fleet Connected Vehicles Pilot
Replies
3
Views
342
Pfizer
anonymous
Joe Urban
Replies
10
Views
850
Zimmer
anonymous
Transparent
Replies
5
Views
206
Intercept Pharma
anonymous
Stock uptick
Replies
6
Views
817
Bristol-Myers Squibb
anonymous
cafead
Marinus cuts 45% of staff after key medicine stumbled in pair of phase 3 trials
Replies
0
Views
17
Pharma/Biotech Companies - In the News
cafead
cafead
Zimmer looking at Sintx for spine and total joints?
Replies
127
Views
7K
Zimmer
anonymous
Company cars
Replies
91
Views
29K
Novartis
anonymous
Co promote with Kowa pharmaceuticals
Replies
2
Views
171
Arcutis
anonymous
Keep Spinning Boys
Replies
1
Views
67
AYTU BioPharma
anonymous
Enema
Replies
50
Views
5K
Patterson Dental Supply
glorianonymous
Just when you thought it couldn’t get worse in Ophthalmology…
Replies
139
Views
12K
Regeneron
anonymous
Immunology
Replies
2
Views
671
Bristol-Myers Squibb
anonymous
Phyllis G
Replies
18
Views
7K
UCB Pharma
anonymous
ImmunityBio
Replies
51
Views
7K
Syneos Health
anonymous
What does Raymond Debanne thinks?
Replies
1
Views
113
Lexicon Pharmaceuticals
anonymous
Top Bottom
Back
Post thread…